Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network Study
Listen to this summary
The authors aimed to investigate the association between semaglutide use and the risk of neovascular age-related macular degeneration (NVAMD) in adults with type 2 diabetes. Their retrospective study, utilizing data from the OHDSI network, found no significant differences in NVAMD risk between semaglutide users and those using other diabetes medications, suggesting that semaglutide does not increase or decrease the risk of NVAMD.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More in Ophthalmology
View all →Aug 6, 2026 · Lancet (London, England)
[<sup>177</sup>Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial
Aug 5, 2026 · American journal of ophthalmology
No-History IOL Power Calculation After Myopic Laser Vision Correction: A Multicenter Retrospective Database Study of 14 Formulas With and Without Posterior Corneal Curvature
Aug 5, 2026 · The New England journal of medicine
Syncope
Aug 5, 2026 · American journal of ophthalmology
Neighborhood Socioeconomic Deprivation and Adherence to Diabetic Retinopathy Screening Guidelines
Aug 4, 2026 · American journal of ophthalmology
In Vivo Microscopic Assessment of Ocular Surface Changes Induced by Antiglaucoma Medications
Aug 4, 2026 · American journal of ophthalmology
Optical coherence tomography-guided focal navigated laser photocoagulation in central serous chorioretinopathy: a non-inferiority study
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


